Inhibition of proliferative potential by the transfection of siRNA for APN/CD13 in ES-2 cells in a 4-day modified MTT assay

<p><b>Copyright information:</b></p><p>Taken from "Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells"</p><p>http://www.biomedcentral.com/1471-2407/7/140</p><p>BMC Cancer 2007;7():140-140.</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC2000898.</p><p></p> Analysis of the proliferation rate was performed as described in "MATERIALS AND METHODS". si-CD13-transfected cells showed almost no growth, whereas the si-cont-transfected cells grew similarly to the parental ES-2 cells. ; si-cont-transfected cells, ; si-CD13-transfected cells. Data are expressed as the mean ± SD of four independent experiments. *; < 0.01, **; < 0.001